Organizaational Change

A
STUDY ON
HUMAN RESOURCE ROLE AFTER IMPLEMENTING CHANGE
MANAGEMENT
WITH REFERENCE TO:
Dr. REDDY’S LABORATORY- PYDIBHIMAVARAM SRIKAKULAM -(AP)
A project report submitted to the Andhra University in partial fulfillment of the

requirements for the award of the degree of
Master of Business Administration

Submitted by
S.Bharathi
Regd.No.118232102058
Under the guidance of
M.N.SASTRY
Associate professor
======================================================================
PYDAH COLLEGE OF ENGINEERING & TECHNOLOGY

Affiliated to: ANDHRA UNIVERSITY
GAMBHEERAM-VISAKHAPATNAM
DECLARATION
I hereby declare that this project entitled as --”A Study on

Human Resource Role After Implementing Change Management
with reference to Dr.Reddy’s” being prepared by me to submit to
Andhra University, Visakhapatnam in partial fulfillment for the
award of Degree of Master of Business Administration is entirely my
own efforts an original work and it has not been submitted to any
other university or institution for the award of any degree or
diploma.
S.Bharathi
Regd no.118232102058.
Place: Gajapathinagaram
Date:
ACKNOWLEDGEMENT
I take this opportunity to evoke my sincere thanks and heartfelt gratitude to

Mr.Subrahmanyam Sir, Assistant HR Manager of Dr.Reddy’s Laboratory-
Pydhibheemavaaram for his cooperation and support all the time during my project
work. I am also thankful to entire staff of the HR department for their cooperation and
support without which this project report would not have been prepared to this
magnificent work.
I express my reverence and regards to my project guide M.N.Sastry-Associate

Professor, for his excellent guidance and relenting suggestions and corrections made
by him.
I wish to extend my sincere regards to the Director Sri S. Sarabandi, Pydah College
PG Courses for his motivation and help in executing the project work for which
provided official clearances and valuable suggestions.
I am also thankful to the Head of the department, Professor Chiranjeevi Rao whose
helped me periodically by way of suggestions and information.
I am also thankful to all the people who are directly and indirectly helped me in
completing my project report. It is not practicable to mention all the names. However
one whom I cannot undermine their importance in my carrier goal that is my parents
without their support and help nothing could be possible for me.
(S.Bharathi)
CONTENTS
CHAPTER -1 Page No.
➢INTRODUCTION TO THE SUBJECT

➢ OBJECTIVE OF THE STUDY
➢ SCOPE OF THE STUDY
➢ NEED OF THE STUDY
➢ METHODOLOGY
➢ LIMITATIONS OF THE STUDY 11
CHAPTER -2
➢ INDUSTRY PROFILE
➢ COMPANY PROFILE
CHAPTER-3
➢ THEORETICAL FRAMEWORK
CHAPTER-4
➢ QUESTIONARE & ANALYSIS
CHAPTER-5
➢ FINDINGS
➢ SUGGESTIONS
➢ CONCLUSION
BIBLOGRAPHY
ANNEXURE
2
CHAPTER - I
2
INTRODUCTION
Among all other resources “Human resources” of any organization consider

as operating resource available in skilled and unskilled, educated and lesser educated
people, who perform their activities as per assigned task to them. Human resource
management (H.R.M) is concerned with the personnel policies and managerial
practices and systems that influence the workforce. In broader terms, all decisions that
affect the workforce of the organization concern the H.R.M function.
Major H.R.M responsibilities include work design and job analysis, training
and development, recruiting, compensation, team-building, performance management
and appraisal, worker health and safety issues, as well as identifying or developing valid
methods for selecting staff. Apart from these activities the HR manager is also
responsible for the growth of the company. So, he has to understand market situation
and according to it he has to make changes in the organization for the development of
the company.
Change is the necessity not optional for every individual and every
organization. Sticking to the same old methodology which may prove obsolete can
lead to rejection. So therefore need to incorporate change in the organization when
time arises at highest priority to keep foothold in the market firmly.
Similarly, a change in organization is also very important. Without initiating

necessary changes an organization cannot survive in the market. Organizational
change is both the process in which an organization changes its structure, strategies,
operational methods, technologies, or organizational culture to affect change within
the organization and the effects of these changes on the organization. Organizational
change can be continuous or occur for distinct periods of time.
It is about reviewing and modifying management structures and business

processes. Small business must adapt to survive against bigger competitors and grow.
Change refers to bringing a shift in the way the activities are performed, work is done,
problems are solved. Basically, a new approach to deal with everything which would
give a positive and successful outcome.
2
This process of change is not easy and is time-consuming but at the end of it,
we realize that it was worth it. All organizations undergo ongoing change, and
studying the ways organizations change provides perspective on the process.
Change mainly comes due to technological upgradation or invention of new

technology, which supersede the existing or old technology which compel the
organization to adopt new technology by replacing old one And Business also
changes due to structural adjustment which take in many forms like merger,
acquisition, divestiture, joint venture, technology implementation, organizational
restructuring, or regulatory compliance. It can also come from new leadership,
strategic decisions to change direction to position for growth or react to changing
market conditions.
Two Opposing forces influence change in an organization - One that drives for
change and one that resist. Driving forces initiate change and keep it going. This may
be external or internal. Resisting forces act against the driving forces of change. They
are usually internal.
Organizational change comprises four main issues:- Content, Contextual,

Process and Criterion. The Key elements for Success in Organizational Change are
Plan for long-term, Empower people, Encourage, enable and develop people to be
active in the change, Make the strategic change process free from autocracy and
interference, Establish forums to communicate methods to review and implement
change.
There are five types of Organizational Changes. They are:- Planned and
Unplanned change, Episodic and Continuous change, Development change,
Transitional change and Transformational change. The Change Process is comprising
of three stages:- Unfreezing Stage(Facing the Problem), Moving Stage(Creating a
New State) and Refreezing Stage(Maintaining the change).
There are so many barriers to Organizational change. Individual Barriers like

Economic fears, Fear of the unknown, Fear of social disruptions, Effort, Fear of loss
of power and autonomy, Commitment to the old position and Organizational Barriers
like Structural inertia, Work group norms, Threat to existing balance of power, Board
of Directors etc
2
.
There are so many areas we have to focus on Organizational change. These
areas include goals and strategies, Technology, Job design, Structure, Processes and
People.
Similarly, Dr.Reddy’s Laboratories Limited has undergone the process of

change in their organization with a view to stand up in the competitive market and
achieve sustainable growth and to meet the customer needs and expectations. It is in
the hands of management of Dr.Reddy’s Laboratories how to bring that change
through the changing in HR Strategies and Policies and conducting training sessions
to make aware their employees to the present change and development.
2
OBJECTIVES OF THE STUDY
The overall focus of the study is to observe how Dr.Reddy’s Laboratory

Limited, successfully implemented the thought out change and mentally prepared the
employees(HR) for organization’s success.
The following are the key factors brought the change in work culture for companies
objective, my study objective was to ascertain those factors responsible for bringing
change in Dr.Reddy’s Laboratory. How much HR department contributed bringing
organizational change.
1. How organizational change is undertaken in the Dr.Reddy’s Laboratories

Limited.
2. Evaluated the functioning and process of organizational change in Dr.Reddy’s

Laboratories Limited.
3. To find out the outcome of change at Dr.Reddy’s Laboratories among the

employees.
4. Study focused another aspect to find out the gap if any, between the
organization’s expectations and the employees expectations.
To examine the impact of change on employees work life, work culture, work life
balancing and organizational performance.
2
NEED FOR THE STUDY
1. The basic need of the study is to know the various changes in the organization.
2. To know how the organization is identifying and implementing the changes for the
development of organization.
3. To study the employee satisfaction towards the training sessions conducted by the
company.
4. This study helps the organization to improve the changes conducted by them.
5. This study depicts whether the company is focusing on the changes in the
environment.
2
RESEARCH METHODOLOGY
The accuracy of the collected data is of great significance for drawing correct and valid
conclusion from the investigation. The information for the study is obtained from two
sources namely.
➢ Primary Sources
➢ Secondary Sources
Primary Sources: It is the information collected directly without any references. It is

mainly through interactions with concerned officers & staff, either individually or
collectively; some of the information has been verified or supplemented with personal
observation. These sources include:
➢ Consultations with the various departments Managers of Dr.Reddy’s.
➢Interaction with employees of Dr.Reddy’s.
Secondary Sources:
Sample size :
Among the total contract employees and department head,100 employees were taken as
sample for the questionnaire.
Sample test:
Random sampling technique is used for analysis the questionnaire.
Random sampling:
Random sample is a subset of individuals chosen from a larger set a population. Each
individual is chosen randomly and entirely by chance, such that each individual has the
same probability of being chosen at any stage during the sampling process, and each
subset of k individuals has the same probability of being chosen for the sample as any
other subset of k individuals. This process and technique is known as random sampling.
2
LIMITATIONS OF THE STUDY
➢ Time was the major constraint as the mentioned period was not enough to collect
the data in detail.
➢ A sample size was restricted to only 100 employees.
➢ Lack of secondary sources such as magazines.
2
CHAPTER-II
- INDUSTRY PROFILE
- COMPANY PROFILE
2
INDUSTRY PROFILE
The pharmaceutical industry in India ranks 3rd in the world terms of volume and
14th in terms of value. According to department of pharmaceuticals, ministry of Chemicals
and Fertilizers, the total turnover of India’s pharmaceuticals industry between 2017 and
September 2018 was US$17.27 billion.
India is the largest provider of generic drugs globally. Indian pharmaceutical sector
industry supplies over 50 per cent of global demand for various vaccines, 40 per cent of
generic demand in the US and 25 per cent of all medicine in UK. India enjoys an important
position in the global pharmaceuticals sector. The country also has a large pool of scientists
and engineers who have the potential to steer the industry ahead to an even higher level.
Presently over 80 per cent of the antiretroviral drugs used globally to combat AIDS
(Acquired Immuno Deficiency Syndrome) are supplied by Indian pharmaceutical firms.
The pharmaceutical sector was valued at US$ 33 billion in 2017. The country’s
pharmaceutical industry is expected to expand at a CAGR of 22.4 per cent over 2015–20 to
reach US$ 55 billion. India’s pharmaceutical exports stood at US$ 17.27 billion in 2017-
18. In 2018-19 these exports are expected to cross US$ 19 billion.
Indian companies received 304 Abbreviated New Drug Application (ANDA)

approvals from the US Food and Drug Administration (USFDA) in 2017. The country
accounts for around 30 per cent (by volume) and about 10 per cent (value) in the US$ 70-
80 billion US generics market.
India's biotechnology industry comprising bio-pharmaceuticals, bio-services, bio-

agriculture, bio-industry and bioinformatics is expected grow at an average growth rate of
around 30 per cent a year and reach US$ 100 billion by 2025.
The government started to encourage the growth of drug manufacturing by Indian

companies in the early 1960s, and with the Patents Act in 1970. However, liberalization in
90s by the former Prime Minister P.V.NarasimhaRao and the then Finance Minister, Dr.
Manmohan Singh enabled the industry to become what it is today. This removed
composition patents from food and drugs, and though it kept process patents, these were
shortened to a period of five to seven years.
2
The Lack of patent protection made the Indian market undesirable to the
multinational companies that had dominated the market. Whilst the multinationals
streamed out, Indian companies carved a niche in both the Indian and world markets with
their expertise in reverse-engineering new processes for manufacturing drugs at low costs.
Although some of the larger companies have taken baby steps towards drug innovation, the
industry as a whole has been following this business model until the present.
India's biopharmaceutical industry clocked a 17 percent growth with revenues of

Rs.137 billion ($3 billion) in the 2009-10 financial year over the previous fiscal. Bio-
pharma was the biggest contributor generating 60 percent of the industry's growth at
Rs.8,829crore, followed by bio-services at Rs.2,639 crore and bio-agri at Rs.1,936 crore.
The number of purely Indian pharma companies is fairly low. Indian pharmacy
industry is mainly operated as well as controlled by dominant foreign companies having
subsidiaries in India due to availability of cheap labor in India at low cost.
In 2002, over 20,000 registered drug manufacturers in India sold $9 billion worth of
formulations and bulk drugs. 85% of these formulations were sold in India while over 60%
of the bulk drugs were exported, mostly to the United States and Russia. Most of the
players in the market are small-to-medium enterprises; 250 of the largest companies
control 70% of the Indian market. Thanks to the 1970 Patent Act, multinationals represent
only 35% of the market, down from 70% thirty years ago. The Quality of drugs and APIs
(Active Pharmaceutical Ingredients) made by Indian pharmaceutical companies is often
poor. In the past three years 2015 - 2017, there were 31 FDA warning letters to Indian
pharmaceutical companies citing serious Data Integrity issues, including data deletion,
manipulation or fabrication of test results, see “An Analysis Of 2017 FDA Warning Letters
On Data Integrity” By Barbara Unger, Unger Consulting Inc.
Exports of pharmaceuticals products from India increased from US$6.23 billion in

2006-07 to US$8.7 billion in 2008-09 a combined annual growth rate of 21.25%. Some of
the major pharmaceutical firms include Sun Pharmaceutical, Healthcare, Dr.Reddy’s and
Piramal Enterprises.
Indian companies are also starting to adapt their product development processes to
the new environment. For years, firms have made their ways into the global market by
those that can afford it have set their sights on an even higher goal: new molecule
discovery. Although the initial investment is huge, companies are lured by the promise of
2
hefty profit margins and thus a legitimate competitor in the global industry. Local firms
have slowly been investing more money into their R&D programs or have formed alliances
to tap into these opportunities.
Pharmaceutical Industry is very much dependent upon the developments and

discoveries that are made to search new types of drugs and also to search for new kind of
medicines. One can also see differences within the industry regarding the same drug or
report and different companies within the Pharmaceutical Industry look to follow different
paths for the same thing. Drug discovery and drug innovation are two very aspects in the
pharmaceutical industry.
Drug Discovery:
Drug discovery is a process through which potential drugs are designed or

discovered. It has been observed in the past that most of the drugs were invented by means
of isolating the active component from remedies which are traditional in nature or through
another kind of discovery known as serendipitous discovery. Drug Development:
This process is taken forward after the discovery is done and a chemical molecule is
identified as potential drug. The development takes place immediately after that as the
component is turned into a medicine. This is considered as a very important process and
has great importance in the Pharmaceutical Industry. Global Pharmaceutical Industry
The global pharmaceutical industry is a multinational industry that is highly

regulated capital intensive and driven by large research and development expenditures. The
industry is primarily privately owned and is technologically sophisticated. Then strong
growth in the ten European market joined the European Union in 2004 helped the boost of
European Sales. Of the leading product classes in 2005, cyst statics and angiotensin-II
inhibitors generated the greatest year on year growth. There were 16 blockbuster drugs in
2005, generating combined sales of US $ 18.1 billion. The total pharmaceutical sales from
the top companies accounted for more than 40% of the total maket. Despite a growth rate
of 7% down sliding from 2004 and the lowest since 1998,in 2005 the total pharmaceutical
sales reached US $ 602 billion.
Among the ten leading international markets combined, which account for 81% of
worldwide sales, audited growth was just 5.7% down from 7.2% in 2004. The United
States accounts for almost half of the global pharmaceutical market, with $289 billion in
2
annual sales followed by the EU and Japan. Emerging markets such as China, Russia,
South Korean and Mexico outpaced that market, growing a huge 81% US profit growth
was maintained even whilst other top industries saw declined growth or no growth. Despite
this pharmaceutical industry is and has been for years the most profitable of all businesses
in the U.S. In the annual Fortune 500 survey, the pharmaceutical industry topped the list of
the most profitable industries, with a return of 17% on revenue. Top Pharma Companies in
India 2017 are:
1. DR REDDY'S LABORATORIES
Dr. Reddy's Laboratories is a Pharmaceutical company which is based out of

Hyderabad in India founded by KallamAnji Reddy.
It the third largest pharmaceutical company in the country with a market

capitalization of INR 640 billion. It is spread in over 100 countries with main operations in
India, Europe, US and Russia.
Its Global Generics i.e. its India business came into existence in 1986 with the brand
Norilet and since then the company has been maintaining a good and balanced portfolio of
specialty and mass therapies.
The company holds niche strengths in research in the areas of cardiovascular

indications,anti-infective and inflammation and metabolic disorders. Dr. Reddy's Lab
reaches out to approximately three lakh doctors on a regular basis with its high sales force
to ensure optimal inventory through consumption based replenishment system.
Dr. Reddy's Laboratories success can be attributed to its supply chain management,
efficient implementation of NPD (New Product Development) and high corporate
governance standards.Dr. Reddy’s Labs always aims to produce high quality and
affordable generics to reduce the number of diseases in the country. It has about 6
production facilities in India as well as one manufacturing facility in Mexico. The company
currently operates in more than 20 countries and produce pharmaceutical products in the
areas of Gastroenterology, Cardiology, Dermatology and Pediatrics.
Research and Development is one of the main areas and it heavily invests in this
area. The investment amounted to 1790 crores. Some of the top API (Active
Pharmaceutical Ingredients) are Ibuprofen, Naproxen and Finasteride.
2
Revenue: 15470.82 Crore INR
Profit: 2001.34 Crore INR
R&D Spent: 1783.42 Crore INR
2. LUPIN PHARMACEUTICALS
Lupin Pharmaceuticals was established in 1968 by DeshBandhu Gupta and focused
majorly on Products and services like Brand Formulations, Generics, APIs, Biotechnology
and Drug discovery. It is the second largest Pharma Company in India with a market
capitalization of about INR 770 billion. It is a US owned subsidiary of Lupin Limited and
has shown tremendous growth potential in therapeutic areas like Asthma, Oncology,
Cardiology and Diabetology. The company is headquartered in Mumbai in the state of
Maharashtra.
The company is named after Lupin flower for the inherent qualities that flower
possess. As the flower grows it nourishes the soil. In the same way Lupin has been
nourishing the lives of people since its inception.
The company gained much recognition when it became world’s largest

manufacturers of TB drugs. The company is succeeding globally with its strong foothold in
advanced markets due to its effective and efficient STP (Segmentation, Targeting and
Positioning) of its products. It is also one of the top companies in South Africa, Japan and
US market.
Lupin has manufacturing facilities in five cities in India and also one site is in
Thailand which is US FDA and WHO approved. It also has state-of-the art research
facilities in India which work in collaboration with global companies and laboratories The
R&D expenses amounted to 1600 crores which show that R&D is the driving force in the
discovery of new drugs and technology led innovation.
Lupin Pharmaceuticals is also helping the nation by its CSR activities. Its aim is to
help rural people by its rural development projects which started in Bharatpur district of
Rajasthan.
2
R&D Spent: 1600 Crore INR
3. CIPLA PHARMACEUTICALS
Cipla Pharmaceuticals is a global company which was founded in 1935 by Dr.K.A

Hamied and its main mission is to provide medical support to every patient.
It is one of the biggest pharmaceutical and biotechnology companies in India today

and has presence in around 170 countries including Europe, South Africa and North
America. APIs, Veterinary and Formulation are its highlighted products and services.
It is headquartered in Mumbai in the state of Maharashtra. Cipla mainly develops

medicines to treat diseases of arthritis, weight control, depression and cardiovascular
diseases. Cipla is the world’s largest antiretroviral drugs developer and sells APIs as well as
personal care products to other manufacturers. Cipla has well-defined portfolio and
innovative Research and Development facilities for developing innovative systems for
drug delivery both for existing and new drugs as well as its major focus is on developing
new medical devices. Cipla spends heavily on research and development and this financial
year it spend around 940 crores. Cipla has a very well- spread distribution network and a
strong presence in the retail prescription market in India. Company always put quality on
the fore-front and adheres to all the regulatory standards. Cipla has 34 manufacturing
facilities in India which is spread across eight cities and are approved by major regulatory
authorities.
R&D Spent: 938.81 Crore INR.
4. CADILA PHARMACEUTICALS
Cadila Pharmaceuticals is an Indian pharmaceutical company which was founded in

1951 with a mission to provide affordable healthcare for people. The company was
2
founded by MrIndravadanAModi and is headquartered in Ahmedabad in the state of
Gujarat. Cadila sells as well as manufactures Active Pharmaceutical Ingredients (APIs) and
finished Formulations in over 80 countries around the globe. In 1995, the company was
restructured into 2 separate companies namely Cadila Healthcare and Cadila
Pharmaceuticals. The company offers formulations in the therapeutic areas like
cardiovascular, analgesics, anti-infectives, antibiotics, respiratory agents and
antidiabetics.
Cadila believes in strong scientific collaborations with world class institutions to

develop medical treatments for unmet needs. In 2013 they joined hands with Helperby
for antibiotic drug research and development. The company has a very large production
facilities located at Dholka in Gujarat, Samba, Jammu and at Addis Ababa in Ethiopia.
It is the first company to get ND (New Drug) approvals for clinical trials to be
conducted in India. The company has well established R&D facility at Dholka in Gujarat
and it spends high on its research of new drugs and formulations. The company spend
almost 640 crores in its R&D this financial year.
The company is also first to introduce Rabeloc in the world. It is the only Indian
manufacturer which manufactures Hyaluronic and Streptokinase products.
5. AUROBINDO PHARMACEUTICALS
AurobindoPharma Limited is a pharmaceutical company established in 1986 by Mr.

P.V. Ramprasad Reddy with other highly committed professionals. The company has its
headquarters in Hyderabad in India and AurobindoPharma started its operations in 1988
with a single unit which manufactured SSP (Semi-Synthetic Penicillin) at Pondicherry.
AurobindoPharma is present in therapeutic areas like Cardiovascular, Antidiabetics,

Gastroenterology and Neurosciences among others. The company also entered the
2
specialty Generics segment for high margins through its effective production capabilities
and it is also into manufacturing APIs and Formulation products.
The company has dedicated R&D facilities that discovers new drugs and
formulations. This year it invested approximately 400 crores. AurobindoPharma has global
presence exporting its products to around 125 countries and over 70 percent of revenue
from international operations. It has multiple facilities which are approved by leading
regulatory agencies.
The core strengths of Aurobindo Pharma are:
Scales and Leadership- because of its large manufacturing and R&D facilities as well
as its well diversified portfolio.
Operational Excellence- because of technology and know-how for specialty

formulations.
In 2014 AurobindoPharma acquired generic operations of Pharma Company named
Actavis in seven western countries. AurobindoPharma is actively involved in CSR activities
by providing subsidised transport to local people and held medical camps for employees
as well as their families. The marketing partners of Aurobindo include Pfizer and
AstraZeneca.
Revenue:8608.55CroreINR
R&DSpent: 395.90 Crore INR
6. TORRENT PHARMACEUTICALS
Torrent Pharmaceuticals Ltd. Is based in Ahmedabad in India and established in

1959.It was initially promoted as Trinity Laboratories by U.N Mehta and was later known
as Torrent Pharmaceuticals. It is the top player in therapeutic areas of CNS (Central
Nervous System) and CV (Cardiovascular) and has significant presence in Gastro-intestinal,
Diabetology and Anti effective management systems. Torrent currently operates in more
than 40 countries with over 1200 products registered globally.
2
Torrent has seven fully owned subsidiaries in Germany, Brazil, Russia, US,
Philippines as well as Canada. Torrent Pharma with its niche marketing right from the
start and being the company with most number of First launches ensured that it is always
ahead of the competition. It also entered therapeutic segments of oncology and
nephrology.
Torrent Pharma is now looking for more collaborations and marketing of its
products to become the most competitive company worldwide. It has all the technical
capabilities, cost advantages, International accreditations as well as global reach. Torrent
Pharma has earned many awards and accolades including the “Export Excellence Awards”
bestowed by the government of India. It is the sole manufacturer of Insulin Formulations
since 1990’s for Novo Nordisk with dedicated packaging facility for Insulin.
It has world class manufacturing facilities in India situated in Gujarat, Himachal

Pradesh and Sikkim. Torrent is one of the few Pharma companies which realised the
importance of R&D and so it heavily invests here with this year expenses amounting to
around 210 crores to work effectively on drug discovery and development projects.
Torrent Pharma has also acquired the branded formulations of Elder Pharmaceuticals in
Nepal and India and thus expanded its already wide portfolio of Products.
Revenue: 5280 Crore INR
Profit: 1898 Crore INR
7. GLENMARK PHARMACEUTICALS
Glenmark Pharmaceuticals is an Indian company that came to existence in 1977 and

it is headquartered in Mumbai. Glenmark has operations in more than 90 countries with 16
state-of-the-art manufacturing facilities in five countries and six R&D centres. The
formulation business has six manufacturing facilities- 4 in India and 2 overseas.
In India, its manufacturing facilities are located in Maharashtra, Himachal Pradesh,

Goa and Gujarat while overseas facilities are located in Czech Republic and Brazil. It is
operating under three business, which include:
2
Drug Discovery- With striking seven out-licensing deals in drug discovery and 3
R&D centres, Glenmark is the clear leader in this segment. Its effort in discovery of drugs
is focused mainly in the areas of inflammation (Asthma and Arthritis), metabolic disorders
(Diabetes and Obesity) and pain (Inflammatory and Neuropathic pain).
Formulation Business- This business mainly focuses on therapeutic areas such as

Dermatology, Respiratory, Cardiac, Diabetes, Oncology and Gynecology.
Glenmark Generics Ltd is a subsidiary of Glenmark Pharmaceuticals which focuses

on key niche segments like Dermatology, Hormones, Oncology and modified products.
Glenmark has significance presence across emerging economies in branded

generics market and is enhancing its marketing network in both domestic and
international markets. It is a leading player in discovering new molecules both NCEs (new
chemical entity) and NBEs (new biological entity). It heavily invests in its R&D spending
around 290 crores.
Glenmark has seven molecules which are under various stages in clinical and pre-
clinical trials. The molecules which are under clinical trials are Crofelemer (It can become
India’s first NCE launched across emerging markets), GRC17536, GRC15300 and
Vatelizumab. It has also won many awards and accolades for exceptional innovations and
patents.
8. SUN PHARMACEUTICALS
Sun Pharma is an Indian pharmaceutical company that was founded by

DileepShanghvi in 1983. It is headquartered in Mumbai, Maharashtra. It manufactures as
well as sells APIs (Active Pharmaceutical Ingredients) in India as well as US.It started in
Vapi with 5 products that treated Psychiatry ailments. In 1987, cardiology products were
introduced and after that in 1989, Gastroenterology products were introduced. Today Sun
Pharma is the market leader in Psychiatry, Cardiology,Ophthalmology, Neurology,
Gastroenterology and Nephrology. Sun Pharma has a drug named Synriam that is very
2
effective in treating Malaria which is one of the most common infectious diseases in the
world and also provide ARV (Anti-Retroviral) therapy which helps in fighting the war
against AIDS.
Sun Pharma acquired Ranbaxy Laboratories in 2015 which is one of the biggest
acquisitions ever in the Pharmaceutical industry and became the largest pharmaceutical
company in India and 5th largest in the world. It also acquired GSK’s Opiates business in
Australia the same year. Its state-of-the-art manufacturing facilities are located in five
continents and around 150 countries majorly in India, US, Canada, Ireland, South Africa,
Malaysia and Mexico.
Sun Pharma sees value when it invests in its Research and Development and thus
invests heavily in order to upgrade its technology and make robust products for diverse
markets. Its R&D expenditure was around 860 crores in FY15-16.
Sun Pharma always focus on quality in all its operations be it testing, manufacturing
or R&D of its pharmaceutical products. This year in 2016, Sun Pharma is set to launch its
eye-care drug named BromSite which had already been approved by US FDA in April.
Profit(Loss): (1213.08) Crore INR
9. DIVIS LABORATORIES
Divis Laboratories was established in 1990 with its fundamentals in research and
development. It is mainly focused on developing APIs (Active Pharma Ingredients) and
Intermediates.With an experience of five years, Divis Labs established its first
manufacturing facility in 1995 after helping many companies with its consulting strengths.
The company has two manufacturing facilities today or units.One is at Hyderabad where
the plant has 13 multi-purpose production blocks with scope of further expansion. The
other one is at Visakhapatnam with 14 production blocks. Both the facilities are primarily
aimed at manufacturing APIs and advanced intermediates for discovery compounds,
building blocks for peptides and nucleotides as well as carotenoids and chiral ligands.
Each of the plants have their R&D centre thatmainly develops alternative synthesis routes
2
to achieve non-infringement of patents and optimise products without sacrificing
quality.Divis Laboratories is truly a global company in its outlook and strive to attain best
standards in quality.
The company also exports its products to American and European countries and has
two subsidiaries- Divis Laboratories (USA) and Divis Laboratories Europe
AG.Thecompanyhas its R&D as its strengths and invested approximately 40 crores to fuel
its research. The two other strengths are its technologies by which it handles all the
hazardous chemicals effectively and Quality units which is further divided into Quality
Assurance (QA) and Quality Control (QC) units. Divis Labs has won many awards for its
best practices and safety management systems in its endeavour to achieve something
great.
10. PIRAMAL ENTERPRISES
Piramal Enterprises which was formerly named as Nicholas Piramal is one of the
largest Pharma companies in India. The company was founded in 1988 and has its
headquarters in Mumbai in the state of Maharashtra. Ajay Piramal is the current
chairman of the company and It is a part of Piramal Group, its healthcare division forms a
major part of the group.
Apart from Healthcare, Piramal Group is also operating in areas of retail, glass
manufacturing as well as real estate. The Piramal Healthcare operates two divisions which
are Pharma and Healthcare solutions. The manufacturing facilities for Healthcare
solutions is located in Himachal Pradesh and Maharashtra while manufacturing facilities
for Pharma solutions are located in Tamil Nadu, Andhra Pradesh, UK and Canada. PHL has
its presence globally in Asia, North America and Europe.
It’s OTC and Ophthalmology division includes popular products like Equal, Caladryl
and Saridon. The compounds are optimised and discovered by life sciences division in the
2
areas of Imaging and Bio-Orthopaedics. It is the only company with a complete portfolio
of IA (Inhalation Anesthesia) drugs and is the third largest player in global IA market.
In 2015, Piramal expanded its ability to make sterile injectable products by

acquiring Coldstream Laboratories. Piramal invested approximately 60 crores to fuel its
R&D division and make innovative products.
Revenue: 3477.53 Crore
INR Profit: 1061.15 Crore INR
MAJOR PLAYERS:
The top ten Indian pharmaceutical companies in terms of nets sales in 2019 are:
S.No Company Name Net Sales
1 Cipla 11,389.90
2 AurobindoPharma 10,269.90
3 Lupin 10,080.58
4 Dr.Reddy’s labs 9,359.30
5 Sun Pharma 7,923.84
6 Glenmark 6,431.88
7 Cadila Health 5,809.90
8 Alkem Lab 5,300.26
9 Torrent Pharma 4,248.24
10 Divis Lab’s 3,815.94
2
The top 10 pharmaceutical industries in world basing on net sales in 2019 are:
S.No Company Name USD$ (billons)
1 Johnson & Johnson 61.11
2 Roche 42.25
3 Pfizer 39.69
4 Novartis 38.63
5 Bayer 32.17
6 Merck & Co 31.03
7 Glaxo Smith Kline 30.08
8 Sanofi 28.81
9 Abb Vie 24.45
10 Abbott Laboratories 22.81
2
COMPANY PROFILE
Dr. Reddy's Laboratories Limited is an integrated global pharmaceutical

company, committed to providing affordable and innovative medicines for healthier
lives. Dr. Reddy's was founded in 1984 by Dr. KallamAnji Reddy. He is a well-
known Indian scientist, entrepreneur, and philanthropist. He is also the recipient of
Padma Shri (2001) and Padma Bhushan (2011), the fourth and third-highest civilian
awards bestowed by the Government of India. He was also named the 'Executive of
the Year' at the Bio Pharma Industry Asia Awards in 2011. which have been created
to honour and generate public recognition of the efforts, accomplishments, and
positive contributions of organizations and individuals in Asia's Bio Pharma industry.
Dr. Reddy's Laboratories strive every day to do what matters most to patients,
accelerating access to affordable medicines and finding solutions for unmet needs. Dr.
Reddy's Generics products bring expensive medicines within reach of patients by
helping reduce the cost of therapy. The portfolio consists of all dose forms in multiple
therapeutic areas as well as biologic drugs.
They also serve patients through their partners. For one, they supply other
generics companies with Active pharmaceutical ingredients, which helps them
quickly bring medicines to market and create affordable options to high cost
medicines. They also help innovator companies get their proprietary medicines to
patients faster by providing a range of products and services.
To address unmet patient needs, they develop innovative products that increase
patient convenience and/or enhance a drug's safety or efficacy. These include novel
formulations of currently marketed drugs or combinations of complementary drugs
that address significant unmet needs. They also have an Active drug discovery
program to discover and develop new chemical entities in key therapeutic areas.
2
Vision:
Dr. Reddy's is a global pharmaceutical powerhouse committed to protecting and

improving health and wellbeing. Their vision is to become a discovery-led global
pharmaceutical company.
They will achieve this vision by building:
• Work places that will attract, energize and help retain the finest talent available.
• Organizational culture that relentlessly focused on the speedy translation of

scientific discoveries into innovative products that make a significant difference in
people's lives.
• A global marketing organization that understands and responds needs of the

customer.
Mission:
• To be the first Indian pharmaceutical company that successfully takes its products
from discovery to commercial launch globally.
• Create a customized curriculum design to develop the professionals who will work
with the medical fraternity and the people to make their life healthier.
•Canalize the efforts of specialists from various disciplines to develop knowledge,

skills, and faculty among the students with appropriate value and attitudinal
orientation among them so that they can establish themselves as professionals.
• Carve a space for patient education in health care service Sector in order to enable
them to complement medical fraternity and add value to the health.
A history of continuous growth:
Dr. Reddy's is the research based company with vertically integrated

operations. The company develops, manufactures and markets a wide range of
pharmaceutical products India and overseas. Dr. Reddy's produces finished dosage
forms, Active pharmaceutical ingredients, diagnostic, kits, critical care and
2
biotechnology products. The basic research program of Dr. Reddy's focused on cancer
diabetes, bacterial infections and pain.
Since its inception in 1984. Dr. Reddy's has chosen to walk the path of
discovery and innovation in health sciences R eddy's has been a quests to sustain and
improve the quality of life, and they: heaves had nearly two decades of creating safe
pharmaceutical Solutions with the ultimate purpose of making the world a heather
place. Dr. Reddy's create and deliver innovative pharmaceutical health care solutions
that people enjoy longer, healthier and more productivelives. Reddy's generic
formulations have also become very popular in quality-conscious regulated markets
such as the US and Europe.
In 1973.after gaining six years of experience in the manufacturing and

implementation of new-technologies in bulk drugs from public Sector company
IDPL.Hyderabad. Dr Reddy's decided to start up basic drugs unit at that time there
were few other players in the private Sector at that end of the pharmaceutical value
chain. In 1975, Dr. Reddy's started the construction of uniloids of which he was the
founder-managing director it was here that they made a move that was to become the
hallmark of the group in the years to come. This move was first to construct and stat
R&D laboratory ever before commencing the construction of the plant. Based on the
work done in these laboratories he constructed a plant in 1976 to manufacture, for the
first time in India, drug called "metrodinazole” for the treatment of amoebic dysentery
the drug became a hit.
In 1981, as managing director of standard organics Ltd; Dr. Reddy's aim was to
develop and manufacture a wide spectrum of bulk drugs to enable the pharmaceutical
industry to launch their formulations. Unfettered. There were only a couple of -
pharmaceutical companies at that time with the capacity to develop newer drugs bit
they would not sell the bulk to other formulators.
Dr Reddy's played a major role in pioneering the technology and production of

'sulphamethonazole' an anti-bacterial in India. Another dream was to do it on his own,
because that was the time that his Second experiment with partnership was also
crumbling. He realizes his dream shortly thereafter, then the established Dr. Reddy's
laboratories in 1984.
2
The company has several distinctions to its credit. Being the first
pharmaceutical company from Asia Pacific (outside Japan) to be listed on the New
York Stock Exchange (on April 11, 2001) is only one among then. And as always, Dr.
Reddy's chose to do it in the most difficult of circumstances against widespread
scepticism.
Dr. Anji Reddy's is well known for his passion for research and drug
discovery. Dr Reddy's started its drug discovery programmed in 1993 and within three
years it achieved its first break through by out licensing an anti -diabetes molecule to
Novo Nor disk in March 1997/ With this very small but significant step, the Indian
industry went through a paradigm shift in its imagefrom being known as just
'copycats" to "innovators"! Through its success, Dr. Reddy's pioneered drug discovery
in India. Thereare several such inflections points in the company's evolution from a
bulk drug (API) manufacturer into a vertically integrated global pharmaceutical
company today.
Today, the company manufactures and markets API(Bulk Actives), Finished

Dosages and Biologies in over 100 countries worldwide, in addition to having a very
promising Drug Discovery Pipeline. When Dr. Reddy's started its first big move in
1986 from manufacturing and marketing bulk Actives to the domestic (Indian) market
to Manufacturing and exporting difficult-to-manufacture bulk votes such as
Methyldopa to highly regulated overseas markets, it had to not only overcome
regulatory and legal hurdles but also battle deeply entrenched mind-set issues of
Indian Pharma being seen as producers of' cheap" and therefore Tow quality'
pharmaceuticals.
Today, the Indian Pharma industry, in stark contrast, is known globally for its
proven high quality-low cost advantage in delivering sage effective pharmaceuticals.
This transition, a tough and often-perilous one.was made possible thanks to the
pioneering efforts of companies such as Dr. Reddy's Laboratories.
Dr. Reddy's is a global, vertically integrated pharmaceutical company with a

presence across the value chain, producing and delivering safe, innovative and high
quality finished dosage forms, Active pharmaceutical ingredients and biological
products. Through the Custom Pharmaceutical Services business unit, they provide
2
drug substance and drug product development and manufacturing services on a
proprietary basis.
Established byDr K Anji Reddy with on initial capacity of Rs.25lakhs.
1986- Goes public with listing in Bombay Stock Exchange. o 1987- Obtained first
USFDA approval for ibuprofen API. o 1987- Started formulations operations.
• 1988- Acquires Benzex laboratories.
• 1990- First Indian pharmaceutical company to export Norfloxacin and Ciprofloxacin

to Europe and Far East.
• 1991- Formulations exports to Russia commences
• 1993- Establishes Dr. Reddy's research foundation, drugs discovery programme

starts
• 1995- Dr. Reddy's research files first patent in US.
• 1997- First Indian company to out license an original molecule DRF 2593
(baladlitazone) to Novo Nordisk.
• 1998- licenses anti-diabetic molecule DRF 2725 (Ragaglitzar) to Novo Nordisk.
• 1999- Acquires American remedies in India.
• 2000- Establishes Reddy US therapeutics in USA.
• 2001- First pharmaceutical company in Asia Pacific, outside of Japan to list in

NYSE.
• 2001- Obtains 1st ever 180 day market exclusively for a generic drug (Fluoxetine 40
mg cap) in US.
• 2001- Launches first generic product (ranitidine) in US o 2005- Acquired Roche's

API business in Mexico.
• 2006- Acquired betapharm in Germany.
• 2006- Becomes an AG partner for Merck's Pros car& Zocor in the US.
2
• 2007- Blaglitazone (DRF 2593) enters phase III of clinical trials becoming India's
most advanced NCE.
• 2008- Acquires BASF's formulation manufacturing unit at Shreveport, Lousiana,

USA.
• 2008- Announces launch of US specialty business PromiusPharma o 2009- Enters

into strategic alliance with GSK for emerging markets.
• 2010- Launches Darbepoetinalfa in India under the brand name "Cresp"-world's first
generic Darbepoetinalfa and the only one in India.
• 2011- GlaxoSmithKline and Dr. Reddy's agrees for the sale of US Penicillin facility
and products.
• 2011- FULIFILM and Dr. Reddy's establishes an executive joint venture for
developing, manufacturing and promoting generic drugs in Japan.
• 2011- Launches over the counter fexofenadine in Japan.
• 2011- Expands its R&D centre in Cambridge, United Kingdom.
• 2011 - Launches pegfilgratim in India under the name " Peggrafeel" o 2011-
Approval and launch of fondaparinux.
• 2012- Crosses $2bn in revenues " fastest in Indian Pharma to reach the milestone".
• 2012- Dr. Reddy's and Merck Serono collaborate to develop and commercialize
Biosimilars.
• 2013-Acquires Netherland based Octoplus-NV, a speciality pharmaceutical

company.
• 2018 Dr.Reddy’s Laboratories has launched Chlorthalidone tablets, used treat high
blood pressure , in US market.
• 2018- Dr.Reddy’s Laboratories has launched Levocetiriinedihydrochloride tablets

usp ,5mg,an over-the-counter therapeutic equivalent generic version ofUSB’s Xyal
allergy tablets, in US market as approved by the US Food and DrugAdministration
(USFDA)
2
Values: ‘In pursuit of our purpose of providing affordable and innovative medicines
for healthier lives, we will create an environment of innovation and learning while
continually reaching for higher levels of excellence".
1. Integrity and Transparency: We will uphold the highest standards of integrity

and transparency in all our interactions.
2. Safety: We are committed to providing safe working environments through

continuous improvement of our infrastructure, work practices and behaviour's.
3. Quality: We are dedicated to designing quality into our products and processes to
delight our stakeholders.
4. Productivity: We strive to achieve more with less through a culture of innovation,

continuous improvement and a sustained focus on elimination of waste.
5. Respect for the Individual: We are committed to creating a work environment

that encourages diverse perspectives and upholds the dignity of work and of
individuals.
6. Collaboration and Teamwork: We will leverage expertise and resources from

across our global network to create greater value for our stakeholders.
7. Sustainability: We will create value for all our stakeholders in a manner that
respects our natural) environment and serves the best interests of the communities in
which we live and work.
Culture:
• Customer-Focused and Performance-Driven: where both external and internal

customers are accorded the highest priority, and where everyone is sensitive to
commitments, time and cost, and focused on delivering innovative affordable
medicines globally.
• Entrepreneurial and Innovative where genuine mistakes are tolerated, intelligent

risk-taking is encouraged, and people feel a sense of empowerment.
2
• Egalitarian and trusting where rank, and status consciousness is low; leadership
walks the talk, where credibility and trustworthiness are championed, and leaders
provide access to people, resources, and information.
• Flexible and Adaptive where change is welcome and initiatives are implemented
with sincerity and commitment, diversity is understood and accepted and mutual
respect for diversity and various ethnic cultures coexist.
A) Awards:
• Amity leadership award
• Best practices in HR department in pharmaceutical Sector4l HR summit 2008
• Dun &Bradstreet American express
• Corporate awards-2007
• Best corporate social responsibility initiative-2007 (BSE India).
PROFILE OF DR REDDY’S CTO- 6
History:
Dr Reddy’s laboratories ltd CTO 6 is established with a merger of DR Reddy’s

and Cheminor drugs ltd. Dr.Reddy’s Laboratories (DRL) has merged its sister
concern Cheminor Drugs (Cheminor) with the merger ratio set at 9 shares of DRL for
every 25 shares of Cheminor.
This merger has resulted with, elevating Dr.Reddy’s as the third largest
pharmaceutical player in India, with a post- integration turnover of above Rs. 8 billion
in FY 2000. The management aims at a turnover of over Rs 10 billion in FY 2001
which it should it able to achieve if the growth in its main brands viz. Omez (anti–
ulcer), Nise (anti–pain), Stamlo (cardiovascular) and Ciprolet (anti–infective) in
FY2000 are any indication. These brands contributed over 40% of the company’s
turnover and will continue to be a major driver for the merged company’s top line.
Another driver of the top line would be the generics business in the regulated
markets, which was being undertaken via Cheminor. (Cheminor recently entered the
2
global generics markets with the export of Ranitidine-75Mg and Flouxetine to North
America.
The third driver of the integrated company’s turnover would be the revenues
from any Novel Drug Discovery(NDDS).At present, DRL itself is working on three
new molecules. One is an anti–cancer compound, another was a Cox II inhibitor
(anti–pain) and third was a compound indicated for metabolic disorders. The company
foresees licensing out two of these to MNCs for clinical trials in the near future.
Besides, the company is also working on a new class of diabetes products called
PPAR, expected to have considerable potential.
The main promoter of the group companies, Dr. Reddy’s Holdings (DRH), currently
holds 25.40% in DRL and 35.34 % in Cheminor. The holding of DRH in the merged
entity will be 27.59%.In their individual capacities, Dr. Anji Reddy and his immediate
family members hold 1.76% in DRL and 13.42% in CDL. In the merged entity their
combined holding will be 3.86%.
The merger ratio too seems to be slightly weighted in favors of the Cheminor
considering the fact that its turnover was Rs 2154 m in FY 2000 i.e. around 36% of
the DRL’s turnover. (DRL’s turnover inclusive of American Remedies’ numbers
amounted to Rs 5870 m in FY2000.) Moreover growth in the domestic bulk Actives
market has Actually been negative. However weight age seems to have been given to
the fact that 67% of Cheminor’s turnover is accounted for by exports and the
company has already filed six abbreviated new drug applications (ANDAs) in the US,
four in the European Union apart from another six, which are in the pipeline.
ABOUT CTO 6
Dr. Reddy's laboratory unit-VI familiar as CTO-VI is the largest plant in India,
and it is located in Pydibheemavaram, Srikakulam (dist), Andhra Pradesh. Initially it
was started with sprawling area of 80acres in a village Pydibheemavaram, now it has
been increased to 120 acres. The foundation stone was founded by the founder of
Dr.Reddy's lab Sri K. Anji Reddy. The production commenced under the dynamism
of senior vice president (Technical) and the plant manage. The manufacturing blocks
in the unit were divided into 3 areas.
2
At present there are 14 production blocks and 14 clean rooms. And there are
1269 permanent employees in the plant. Where there are 1180 are classified as
employees and the remaining 89 are classified as workmen. And the remaining
employees are third party either contract labor or people from Consultancy services
like Sodexo etc.
The production blocks 17,18,19 belongs to ecologic. At present ecologic was

acquired by Dr.Reddy’s in the year of 2013.Besides the CTO there is also extension to
plant which is called as SEZ CTO. The company is following good HR practices,
good and fair recruitment policies. Also possessing good career planning and
succession planning.
The departments in the company are as follows.
• HRD
• Finance
• Administration
• Quality assurance
• Quality control
• Project
• Engineering
• Ware house- raw material
• Ware house- engineering
• Safety health and environment (SHE)
• Production
• TSD&R&D
• SCM
2
Structure Designation
Plant Head Arun Gupta
R3A Associate Director
R2B Manager
R2A Manager
R1B Assistant Manager
R1A Assistant Manager
R0B SMT
R0A SMT
The R0A and R0B cadre employees are just intermediate qualified people and
who have attained the age above 18 are recruited in to the company. They will be
properly trained and directly employed in production process.
Apart from employment there were also provided with Graduation in B.Sc.
(chemistry) course with the MOU with Birla Institute and Also GITAM University with
free accommodation and Hostels.
And coming to R1 cadre, they are recruiting the graduates of NIT’s with
chemical engineering and mechanical Engineering through campus placements in
the production department. But coming to R1 Cadre in HR and Finance department
and R2 and above cadre employees are recruited through Lateral Hiring with at least
three or more than three years of experience.
CTO 6 also providing good welfare benefits like canteen and Bus facilities and
also providing Referral Policy to its employees to refer a prosperous employee to the
organization growth.
Employee welfare benefits:
1. Leave travel allowance
2. Medical
2
3. Family health planning limited
4. In house health
5. Employee canteen facility.
Raw materials:
• Methanol
• Toluene
• Ethyl acetate
• Benzene
DISCIPLINE MANAGEMENT:
Discipline is very essential for a healthy industrial atmosphere and the

achievement of organizational goals. The term ‘discipline’ can be interpreted
variously . It is a state of order in an organization. It also means compliance with the
accepted order or proper appreciation of the hierarchical superior – subordinate
relationship. It corrects improper conduct and thus Acts as a force leading to the
observance of roles and regulations.
The concept of discipline emerges in a work situation from the interaction of

manager and workers in an organization. Formal and informal rules and regulations
govern the relationship between a manager and worker. The formal rules and
regulation including work related behavior rules, are codified in the company’s
manual or standing orders.
The term indiscipline can be described as non conformity to formal and

informal rules and regulations. It is necessary to correct indiscipline in an
organization because of its adverse influence on morale and motivation of the
employees as well as organization. Indiscipline leads to chaos , confusion, and
diffusion of results. It gives rises to strikes, go-slows, absenteeism, leading to loss of
production , profits and wages.
2
“Sequence of disciplinary procedure in step by step ”.
Step 1: INVESTIGATION PRLEMINARY
↓
Step 2: CHARGE SHEET
↓
Step 3: SERVICE OF CHARGE SHEET
↓
Step 4: SUSPENSION PENDING QUERY
↓
Step 5: CONSIDERATION OF AN EXPLANATION
↓
Step 6: NOTICE OF ENQUIRY
↓
Step 7: CONDUCTING ENQUIRY
↓
Step 8: RECORDING FINDINGS
↓
Step 9: PUNISHMENT
Industry Pharmaceuticals
Founded 1984
Founders KallamAnji Reddy
Headquarters Hyderabad, Telangana, India
Area served Worldwide
Key people G. V. Prasad (Co-Chairman & CEO
2
Satish Reddy (Chairman)
N. V.P.Narayana (Associate director

HR)
G.A.V.S.Subrahmanyam (HR Manager
Number of employees 23,524 (March 2018)
Number of employees in CTO-VI 1180 (March 2018)
Website www.drreddys.com
2
CHAPTER-III
THEORITICAL FRAMEWORK OF THE STUDY
2
2
INTRODUCTION
Organizational Change in an important characteristic of most organizations

nothing is permanent except change. it is the duty of Management to manage change
properly.
An Organization must develop adaptability to change otherwise it will either be

left behind or be swept away by the forces of change. there are many forces which are
acting on organizations which make the change not only the Desirable but also
invertible. these forces include Technology, market forces, and general socio-
economic development.
These are external forces which necessitate the change in internal

organizational variables like machinery, equipment, and processes, policies and
procedures, structural relationships.
The main concepts involved in organizational change are:-
1. The whole organization tends to be affected by a change in any part of it. For
example, the introduction of new technology in the production department would
have its effect on the purchase, finance, marketing, and other departments.
2. Organizational change takes place in all parts of the organization. but at its
varying rates of speed and decrease of significance.
3. The change may be Reactive or Proactive. when change is bought about due to
the pressure of external forces. It is called reactive change but proactive change is
inserted by the management on its own to increase organizational effectiveness.
4. Organizational Change may affect people, structure, technology and other
elements of the organization.
5. The change results from the pressure of forces, which are both outside and inside
the organization it disturbs the exciting equilibrium in the organization.
2
Recent Organizational changes
Amazon went online in 1995, the e-commerce juggernaut has undergone a slew
of changes. When the seattle - based company first launched its website, all it sold
was books. Gradually, Bezos and his team expanded Amazon’s offerings to include
things like CDs and DVDs.
But Amazon never really stopped changing the inventory it sold.

Bezos said he wanted his store to become the world’s largest, so he worked
hard toward meeting that goal--- whether that meant offering new products,launching
Amazon Prime, launching Amazon Instant Video etc..
Today, Amazon sells more than 200 million products to customers all over the
world. The market responded kindly, and today, Amazon boasts a market valuation of
more than $440 billion. Bezos recently said he hopes Amazon can produce as many as
16 feature films each year. In 2017, Bezos & his team took home three Oscars.
Amazon is a company that can be characterized as changing constantly. To

date, they have been successful, probably because the company is always putting its
customers first and make changes according to it.
2
COCA-COLA
When Asa Griggs Candler founded The Coco-Cola Company in the late 1800s,
there was no way he knew his company would one day be valued at upwards of $180
billion. That’s a lot of money for a business that sells soft drinks. In the 1980s, Coke’s
biggest rival, Pepsi, was aggressively targeting it. This caused Coca-Cola to
reevaluate its offerings.
Eventually, the company decided to concoct a new, sweeter soda. They called it
simply New Coke. Unfortunately, the public didn’t take too kindly to the new
beverage. But Coke’s executives didn’t let the mishap derail their success.
Quickly, management decided to pull New Coke and replace it with the older,
established formula. Coca-Cola Classic was born, and Coke maintained its market
dominance.
Just as quickly as Coke changed to accommodate its customers’ sweeter

palates, it changed direction again when it realized it made the wrong move. Coca-
Cola listened to its customers and enacted change. In fact, it sells more than 500
brands to customers in over 200 countries.
2
Today, many of its offerings — like DASANI, vitamin water and Evian — are
even considered healthy drinks.
In other words, Coca-Cola has consistently strived to diversify its product

portfolio and expand into new markets. By and large, Coke has succeeded in these
efforts.
In the same way, Dr.Reddy’s Laboratories Limited also bring changes in

organizational structure and strive for the growth of their company.
Dr.Reddy’s Laboratories
Dr.Reddy’s Laboratories Limited has introduced some changes as a part of the

organizational change. They make their organization as digitalized and user friendly.
The organization made changes in several fields to increase the quality and output of
the productivity.
It introduced the concepts like SuCCEED, Doc-Hub, My Safety Index, Role

band, JABRA, TechEase and Digitalization in HR Tools, MS Teams, I Hub-2.0, My
Day.
2
Now we will discuss one by one of the above concepts:
Digitalization:
Digitalization is the process of converting information into a digital (i.e.
computer-readable) format, in which the information is organized into bits.
To make organizational day to day activities easily, it introduced different concepts in

it. As a result of it increases it’s day to day transactions and quality. This also
increases the skills of the employees.
As a part of Digitalization the organization introduced I hub-2.0, MS Teams

and My Day.
2
i hub-2.0:
2
In this Digital age and space we live in, quick timely updates make a digital
workplace as a preferred workspace. With the ihub-2.0 we can create a customized
dashboard to meet all the business needs.
Ihub-2.0 gives us a wide range of productive tools just a click away. Customize
our dashboard by selecting our workplace tools and get started.
From our wide range of productivity tools select our most used tools, mark as
our favourite and arrange them across the dashboard with our personal priority list.
In this ihub-2.0 we can have several apps to find the relevant data and
information.
These apps makes the employees and employers easy to know about the details
of organization and employees.
There are several components include in these apps. They are as listed in the
following:
Company Information: By this we can know the details of the company.

These include:
 About Us
 Line of Businesses
 Know about Dr.Reddy’s
 Brand & Leaders
Communication: By this we can know the publications of the company.

These include:
 Annual Report
 Company Fact Sheet
 Company News
 Corporate Presentation
 Sustainability Report
 Brand1
2
HR: It is very useful to both the employees and employers working in the
organization.
These include:
 Performance Management
 People - These include Holiday list, Employee Profile, Recruitment, We care.
 Health & Recognition - These iclude E-Health card, Medical Insurance,

Welldone
 Resignation
Analytics: It includes the global quality operations.
Work: These include the following
 Document Repository - It contains Doc Hub, Document Distribution System
 Purchase & Payments - Foreign Payments, Shopping cards etc.
 Applications - Approvals, Bargain corner, Change control, Change request

system, Document sign, MSN Request, Insurance claiming report.
Self Service:
This is to be used by every individual employee. It contains the following:
 Attendance & Leave - Attendance report, Time & Attendance Management

system(KRONOS), Leave Encashment, Leave Request etc.
 Finance - IT Declarations, Digital Form-16, ESOP Direct etc.

 Travel - Cab Request, Travel Request
 Reimbursement - Revenue Expenses, Reimbursement report, E-cash, Employee
Outstanding Advance Status etc.
 IT support
 Reference Materials - IT Training materials, HR Training materials etc.
2
MS Teams:
It means Microsoft Teams. It helps for effective communication. We can create a

project group in MS Teams, add team members, and initiate conversations.
It helps us to eliminate e-mail entirely for intra-team communication,
Advantages:
 Use ‘@’ to tag the person you want to request for information. Rest of the team
members will be in ‘Cc’ ed automatically.
 Reply in the conversation thread, similar to social media sites, so that all
conversations archived in one place.
 Share files in the project groups through MS Teams.

 Easy access to all the project files in one place for all the team members.
 If you need to update a file, open the file in MS Teams, edit and save, or replace
the existing file with an edited document. No need to send a separate e-mail.
2
JABRA:
It is the instrument that is used to make the communication very effective in all
conference rooms. By this the speed of the communication is very high. With this we
can deliver the messages without any interruptions and time gap.
2
Connect your laptop with the Jabra speaker, which has a built-in microphone, and enjoy
seamless two-way communication at business meetings.
Benefits of using Jabra:
 Immersive sound for calls.
 In-room coverage for two way communication.
Follow these steps:
My Day:
To set the goals and objectives for day to day activities Dr.Reddy’s create an app
called My Day. My Day is an online platform developed by Digital Team to enable the
employees to plan their Meetings, Projects and Personal Tasks in simpler, better
and more effective manner.
Several features like Unified Approvals, Personalized Analytics and important
process integrations will be part of this App. In the first phase of implementation, below
mentioned features are readily available for immediate use-
2
1. Plan your projects/initiatives
2. Note down minutes of meeting
3. Assign and track ad-hoc/quick tasks to oneself and others
With this App, one can easily prioritize his/her day-to-day activities/deliverables
and can track their progress in real time. It will also work as an effective platform of
collaboration for various Cross Functional Individuals/Teams with common
goals/projects as deliverables.
Benefits of My Day:
By this all the employees have to enter their day wise activities in a scheduled
way and they can complete in time to time and they can assess their performance and
activities in daily basis.
2
This can increase the confidence levels and strength of the employees and this
results in increases the organization growth and output. This looks like a calender to
complete all the activities and work with in the given time limit.
TechEase:
To solve the IT related issues and complete the work with in the time limit,
Dr.Reddy’s Laboratories Limited has introduced a helpdesk called TechEase. This
helpdesk consists of a group of people who are working together to solve the IT issues
that are raised in the company.
2
With this the IT problems will be resolved with in the mean time and the work
can be completed without any stoppage. To communicate with the TechEase helpdesk
Dr.Reddy’s has launched a toll free number.
Smarter workplace. Better Experience. Faster Solution.
Dial the new toll-free number for

employees in India.
18001038475
Call from anywhere in India
Are you facing an

IT related issue?
῀ Call TechEase
My Safety Index:
As Dr.Reddy’s Laboratories Limited is a pharmaceutical company, there is a
high amount of manufacturing process is daily occurring in the plant. So, there is a
chance of occurring any accidents or injuries frequently in the manufacturing areas.
To overcome those incidents and injuries Dr.Reddy’s has introduced a new

concept called ‘My Safety Index’.
MSI is a single proactive input lever that represent, safety and health
performance of the Business. It consists elements of Culture improvement and
Management System with an equal weightage on both. The cultural elements are
driven by Unit head and Unit leadership team. The Safety Management System
element are driven by cross functional teams & Safety head of the location to
strengthen the safety system/ processes.
By this they wanted to emphasize that there is Zero Tolerance to any Safety
deviation or deviation in implementing established procedures. They are rolling out a
2
procedure on “Safety Violation & Graded Consequence Management” where in
each BU establish cardinal rules for Safety conduct.
DOCHUB:
To combine all the documents and forms together into a single window and
make the transactions easily, the organization has introduced a new concept called
DOCHUB. This makes the business operations very fast and quick.
Successfully completed the migration of all the effective SOPs, Forms, Work ,
Specifications and Methods into DOCHUB.
2
All creation, revision, approval and distribution of below documents will be on
DOCHUB .
 Standard Operating Procedures and related Forms.
 Specifications.
 Protocols and Reports.
To make the effective use of DOCHUB, the organization provided training

sessions to the employees working in the organization. Also they have created a
helpdesk at CTO Unit-VI to help and handhold the team.
2
Role Band:
The organization re-banding project is a key initiative in the transformation that
will help create a system that is meritocratic, less hierarchical and progressive, thereby
propelling our growth and thus create a foundation for great careers within Dr. Reddy’s.
2
CHAPTER- IV
DATA ANALYSIS AND
INTERPRETATION
2
1. Is the SuCCEED program of the organization is well structured?
a) Strongly Agree b) Agree
b) Disagree d) Strongly Disagree
Options Number of Respondents Percentage
Strongly Agree 16 16%
Agree 68 68%
Disagree 16 16%
Strongly Disagree 0 0%
Grand Total 100 100
Number of Respondents
0%
16% 16%
Strongly Agree
Agree
Disagree
Strongly Disagree
68%
Interpretation:
2
From the above chart, we observe that 16% of respondents are Strongly Agree, 68%
of respondents are Agree, 16% of respondents are Disagree and 0% of respondents
are Strongly Disagree. That means SuCCEED program of the organization is well
structured.
2. Does the SuCCEED program help to improve the quality in the output?
a) Yes b) No
c) Sometimes d) Rarely
Yes 64 64%
No 10 10%
Sometimes 22 22%
Rarely 4 4%
Grand Total 100 100
2
4%
22%
Yes
No
Sometimes
10% Rarely
64%
Interpretation:
From the the above chart, we observe that 64% of respondents said Yes, 10% of
respondents said No, 22% of respondents said Sometimes, 4% of respondents said
Rarely. It is very clear that SuCCEED program help to improve the quality in the
output.
3. Is the Doc Hub Software helpful?
c) Neutral d) Disagree
e) Strongly Disagree
Strongly Agree 4 4%
Agree 68 68%
Neutral 14 14%
2
Disagree 6 6%
Grand Total 100 100
8% 4%
6%
Strongly Agree
14% Agree
Neutral
Disagree
Strongly Disagree
68%
Interpretation:
From the above chart, we observe that 4% of respondents are Strongly Agree, 68% of
respondents are Agree, 14% of respondents are Neutral, 6% of respondents are
Disagree and 8% of respondents are Strongly Disagree. It is very clear that Doc-Hub
Software is helpful.
4. Does the i Hub-2.0 software is User friendly?
a)Strongly Agree b) Agree
2
c) Neutral d) Disagree
Agree 64 64%
Neutral 10 10%
Disagree 14 14%
Grand Total 100 100
0%
14% 12%
Strongly Agree
10%
Agree
Neutral
Disagree
Strongly Disagree
64%
Interpretation:
2
From the above chart, we observe that 12% of respondents are Strongly Disagree, 64%
of respondents are Agree, 10% of respondents are Neutral, 14% of respondents are
Disagree and 0% of respondents are Strongly Disagree. It is very clear that I Hub-2.0
Software is user friendly.
5. Do you think the Recent Role Band change occurred in your organization is fit
enough for all the employees?
c)Neutral d) Disagree
Strongly Agree 6 6%
Agree 36 36%
Neutral 2 2%
Disagree 24 24%
Grand Total 100 100
2
6
14
Strongly Agree
Agree
Neutral
36 Disagree
24 Strongly Disagree
Interpretation:
From the above chart, we observe that 6% of respondents are Strongly Agree, 36% of
respondents are Agree, 2% of respondents are Neutral, 24% of respondents are
Disagree and 14% of respondents are Strongly Disagree. It is very clear that half of the
people are satisfied with the changes in the Role Band and half of the people are not
satisfied.
6. Is the concept ‘My Safety Index’ helpful to all the employees?
Agree 56 56%
2
Neutral 16 16%
Disagree 10 10%
Grand Total 100 100
10 0
18
16 Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
56
Interpretation:
of the respondents are Agree, 16% of respondents are Neutral, 10% of the
respondents are Disagree and 0% of the respondents are Strongly Disagree. It is very
clear that the concept ‘My Safety Index’ is helpful to the employees.
7. Do you require any training session before the introduction of new concepts in
your organization?
a) Yes b) No
c)Sometimes d) Rarely
2
Yes 80 80%
No 4 4%
Sometimes 12 12%
Rarely 4 4%
Grand Total 100 100
4%
12%
4%
80%
Interpretation:
From the above chart, we observe that 80% of respondents said Yes, 4% of the
respondents said No, 12% of respondents said Sometimes and 4% of respondents
said Never. It is very clear that the training sessions are required before the
introduction of new concepts in your organization.
2
8. Do Techease help to solve the IT issues in your organization?
a) Yes b) No
c)Sometimes d) Never
Yes 64 64%
No 30 30%
Sometimes 0 0%
Never 6 6%
Grand Total 100 100
0% 6%
Yes
30%
No
Sometimes
64% Never
Interpretation:
2
From the above chart, we observe that 64% of respondents said Yes, 30% of
respondents said No and 6% of respondents said Never. It is very clear that most of
the people said the Techease help to solve the IT issues.
9. Do you find Techease helpdesk helpful?
Agree 70 70%
Neutral 12 12%
Disagree 8 8%
Grand Total 100 100
2
8 0 10
12
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
70
Interpretation:
Disagree and 0% of the respondents are Strongly Disagree. It is very clear that
Techease helpdesk is helpful.
10. Is your organization digitalized or not?
a) 85-100% b) 60-85%
c)35-60% d) Less than 35%
85-100% 62 62%
60-85% 24 24%
30-60% 10 10%
2
Less than 35% 4 4%
Grand Total 100 100
4%
10%
24%
62%
85-100% 60-85% 30-60% Less than 35%
Interpretation:
From the above chart, we observe that 62% of respondents said 85-100%, 24% of
the respondents said 60-85%, 10% of respondents said 35-60% and 4% of the
respondents said Less than 35%. It is very clear that the organization is digitalized.
11. What are the barriers of quality in your organization?
a) Non-availability of raw materials b) Lack of knowledge
c)Non-availability of skilled labour d) Lack of Time
2
Non-availability of raw materials 8 8%
Lack of Knowledge 54 54%
Non-availability of Skilled labour 12 12%
Lack of Time 26 26%
Grand Total 100 100
8%
26% Non-availability of raw materials
Lack of Knowledge
Non-availability of Skilled labour
12%
54% Lack of Time
Interpretation:
From the above chart, we observe that 14% of respondents said Non-availability of
raw materials, 54% of the respondents said Lack of Knowledge, 12% of the
respondents said Non-availability of Skilled labour and 26% of the respondents said
Lack of Time. It is very clear that the highly barrier of quality in your organization is
Lack of knowledge.
2
12. Are the training sessions conducted on SuCCEED help you in improving your
skills?
Agree 54 54%
Neutral 20 20%
Disagree 8 8%
Grand Total 100 100
4
8 14
Strongly Agree
20 Agree
Neutral
Disagree
Strongly Disagree
54
2
Interpretation:
Disagree and 4% of respondents are Strongly Disagree. It is very clear that the
training sessions conducted on SuCCEED help the employees to improve their skills.
13. Are you satisfied with the new software tool Talent Hub?
a) 85-100% b) 60-85%
c)30-60% d) Less than 30%
85-100% 24 24%
60-85% 56 56%
30-60% 16 16%
Less than 35% 4 4%
Grand Total 100 100
2
NUMBER OF RESPONDENTS
85-100% 60-85% 30-60% Less than 35%
Less than 35%

4%
30-60% 85-100%
16% 24%
60-85%
56%
Interpretation:
From the above chart, we observe that 24% of respondents said 85-100%, 56% of
the respondents said 60-85%, 16% of respondents said 30-60% and 4% of the
respondents said Less than 35%. It is very clear that the employees are satisfied with
the new software tool Talent Hub.
14. Are you comfortable with the Digitalization concept?
a) Yes b) No
Yes 86 86%
2
No 14 14%
Grand Total 100 100
No
14%
Yes
86%
Yes No
Interpretation:
From the above chart, we observe that 86% of respondents said and 14% of
respondents said No. It is very clear that the employees are comfortable with the
Digializtation concept.
15. Is Time of Management System(KRONOS) software is user friendly?
2
a) Yes b) No
c)Sometimes d) Never
Yes 80 80%
No 0 0%
Sometimes 20 20%
Never 0 0%
Grand Total 100 100
0%
20%
Yes
0% No
Sometimes
Never
80%
Interpretation:
2
From the above chart, we conclude that 80% of respondents said Yes, 0% of
respondents said No, 20% of respondents said Sometimes and 0% of respondents said
Never. It is very clear that KRONOS software is user friendly.
CHAPTER –V
SUMMARY
2
Summary
Organizational change is very important to any organization to sustain in the
present market otherwise the companies cannot survive and meet the customer
expectations. Change can be continuous or occur for distinct periods of time.
In this report it examines and investigates that the literature review on changes
happened in the organization. It increases not only the quality and productivity but also
enhances performance and skills of the employees.
This study was a learning experience for me and I came to know the programs
that are introduced in the organization to meet the changes. It also shows that
2
Everyone in the organization is informed about the programs that are conducted.
Though some of them are not informed this can be overcome by communication. The
employees are agreed that the changes that are recently happend in the organization is
helps them to improve their skills and quality.
The changes happened in Dr.Reddy’s Laboratories Limited is very responsive

but still some of the employees cannot understand these changes and importance of it.
So, proper training will be given to the employees about the changes will definitely
increases the company growth and productivity.
In the last but not the least I conclude that all the programs of company related
to the organizational change are highly effective and beneficial to the employees in
giving their best contribution to their personal growth and development as well to
meet the organizational objective.
Findings of the study

After completing the survey and analyzing the responses of the employees
contacted, I came across the following facts.
2
 Organization is following a well designed and widely shared organizational
changing policies.
 Dr.Reddy’s Laboratories Limited is able to achieve its objectives by

conducting adequate training programs on changes that are made in the
organization.
 It is also found that the SuCCEED program help to improve the quality in
the output.
 Some of the employees are not satisfied towards the changes in recent role
band.
 The barrier of quality in your organization is lack of knowledge to the
employees.
 Some of the employees are not satisfied towards the Techease.
 The employees are satisfied with the new software tools.
 Most of the people are comfortable with the Digitalization concept.
2
Suggestions:
On the basis of survey through questionnaire, I hereby humbly propose my
suggestions to carry out further improvement in existing changes in
organizational activities in Dr.Reddy’s Laboratories Limited.
 Organization should also take care to aware the employees about the
changes in the organization.
 The management should give effective training to the employees before

introduction of new concepts in organization.
 Organization should take proper feedback from the employees about

improvement of quality and productivity.
 Organization have to make the changes in role band that will be accepted
by employees.
 The organization must focus on Techease to solve the IT issues.
2
2
QUESTIONNAIRE
1. Is the SuCCEED program of the organization is well structured?
a) Strongly Agree
b) Agree
c) Disagree
d) Strongly Disagree
2. Does the SuCCEED program will help to improve the quality in the output?
a) Yes
b) No
c) Sometimes
d) Rarely
3. Is the Doc Hub Software helpful?
a) Strongly Agree
b) Agree
c) Neutral
d) Disagree
4. Does the i Hub-2.0 software is User friendly?
a) Strongly Agree
b) Agree
c) Neutral
d) Disagree
2
5. Do you think the Recent Role Band change occurred in your organization is fit
enough for all the employees?
a) Strongly Agree
b) Agree
c) Neutral
d) Disagree
6.Is the concept ‘My Safety Index’ helpful to all the employees?
a) Strongly Agree
b) Agree
c) Neutral
d) Disagree
7. Do you require any training session before the introduction of new concepts in
your organization?
a) Yes
b) No
c) Sometimes
d) Rarely
8. Do Techease help to solve the IT issues in your organization?
a) Yes
b) No
c) Sometimes
d) Never
2
9.Do you find Techease helpdesk helpful?
a) Strongly Agree
b) Agree
c) Neutral
d) Disagree
10.Is your organization digitalized or not?
a) 85-100%
b) 60-85%
c) 35-60%
d) Less than 35%
11. What are the barriers of quality in your organization?
a) Non-availability of raw materials
b) Lack of knowledge
c) Non availability of skilled labour
d) Lack of Time
12. Are the training sessions conducted on SuCCEED help you in improving your
skills?
a) Strongly Agree
b) Agree
c) Neutral
d) Disagree
2
13.Are you satisfied with the new software tool Talent Hub-2.0?
a) 85-100%
b) 60-85%
c) 30-60%
d) Less than 30%
14.Are you comfortable with the Digitalization concept?
a) Yes
b) No
15. Is Time of Management System(KRONOS) software is user friendly?
a) Yes
b) No
c) Sometimes
d) Never
2
BIBILIOGRAPHY
Referred Books:
John P.Kotter Leading Change
William Bridges Managing Transitions: Making the Most of Change
Websites:
 www.myreddys.com
 www.scribd.com
 www.brandindiapharma.in
 www.managementstudyguide.com
 www.wikipedia.com
Journals:
Journal of Organizational Change Management
Journal of Strategic Change Management.
2
2

Organizaational Change

Uploaded by

Copyright:

Available Formats

You might also like

Organizaational Change

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Organizaational Change

Uploaded by

Copyright:

Available Formats

A

A project report submitted to the Andhra University in partial fulfillment of the

Master of Business Administration

PYDAH COLLEGE OF ENGINEERING & TECHNOLOGY

I hereby declare that this project entitled as --”A Study on

I take this opportunity to evoke my sincere thanks and heartfelt gratitude to

I express my reverence and regards to my project guide M.N.Sastry-Associate

CHAPTER -1 Page No.

➢INTRODUCTION TO THE SUBJECT

Among all other resources “Human resources” of any organization consider

Similarly, a change in organization is also very important. Without initiating

It is about reviewing and modifying management structures and business

Change mainly comes due to technological upgradation or invention of new

Organizational change comprises four main issues:- Content, Contextual,

There are so many barriers to Organizational change. Individual Barriers like

Similarly, Dr.Reddy’s Laboratories Limited has undergone the process of

The overall focus of the study is to observe how Dr.Reddy’s Laboratory

1. How organizational change is undertaken in the Dr.Reddy’s Laboratories

2. Evaluated the functioning and process of organizational change in Dr.Reddy’s

3. To find out the outcome of change at Dr.Reddy’s Laboratories among the

Primary Sources: It is the information collected directly without any references. It is

➢ Consultations with the various departments Managers of Dr.Reddy’s.

➢Interaction with employees of Dr.Reddy’s.

Random sampling technique is used for analysis the questionnaire.

➢ A sample size was restricted to only 100 employees.

➢ Lack of secondary sources such as magazines.

Indian companies received 304 Abbreviated New Drug Application (ANDA)

India's biotechnology industry comprising bio-pharmaceuticals, bio-services, bio-

The government started to encourage the growth of drug manufacturing by Indian

India's biopharmaceutical industry clocked a 17 percent growth with revenues of

Exports of pharmaceuticals products from India increased from US$6.23 billion in

Pharmaceutical Industry is very much dependent upon the developments and

Drug discovery is a process through which potential drugs are designed or

The global pharmaceutical industry is a multinational industry that is highly

Dr. Reddy's Laboratories is a Pharmaceutical company which is based out of

It the third largest pharmaceutical company in the country with a market

The company holds niche strengths in research in the areas of cardiovascular

Profit: 2001.34 Crore INR

R&D Spent: 1783.42 Crore INR

The company gained much recognition when it became world’s largest

Profit: 2270.70 Crore INR

R&D Spent: 1600 Crore INR

Cipla Pharmaceuticals is a global company which was founded in 1935 by Dr.K.A

It is one of the biggest pharmaceutical and biotechnology companies in India today

It is headquartered in Mumbai in the state of Maharashtra. Cipla mainly develops

Revenue: 11735.18 Crore INR

Profit: 1398.03 Crore INR

R&D Spent: 938.81 Crore INR.

Cadila Pharmaceuticals is an Indian pharmaceutical company which was founded in

Cadila believes in strong scientific collaborations with world class institutions to

Revenue: 6436.52 Crore INR

Profit: 1977.33 Crore INR

R&D Spent: 643.60 Crore INR

AurobindoPharma Limited is a pharmaceutical company established in 1986 by Mr.

AurobindoPharma is present in therapeutic areas like Cardiovascular, Antidiabetics,

The core strengths of Aurobindo Pharma are:

Operational Excellence- because of technology and know-how for specialty

Profit: 1548.83 Crore INR